# Utilization of Adipose-Derived Stem Cells in Cranial Nerve Regeneration: A Comprehensive Review

**Authors:** Nolan Brown, Saarang Patel, Mohammad F Khan, Ryan T Gensler, Hibbah I Khan, Vikas Munjal, Julian L Gendreau, Taylor Reardon

PMC · DOI: 10.7759/cureus.88706 · Cureus · 2025-07-24

## TL;DR

This review explores how fat-derived stem cells may help repair cranial nerves in both animals and humans.

## Contribution

The paper systematically reviews the use of adipose-derived stem cells for cranial nerve regeneration in preclinical and clinical studies.

## Key findings

- ADSCs improved myelination and muscle fiber diameter in cranial nerve injuries.
- Optic nerve studies showed significant improvements in visual function with ADSC treatment.
- Most studies used animal models, with only one involving human cranial nerve injuries.

## Abstract

Large peripheral nerve injuries may require surgical reconnection. Cell-based therapies have also been investigated for nerve regeneration. Within the context of this modern treatment paradigm for peripheral nerve injuries, we investigated the role of adipose-derived stem cells (ADSCs) in the regeneration of cranial nerves. PubMed and Embase databases were used to search for primary studies reporting the use of ADSCs in the regeneration of cranial nerves. A total of 12 studies were included, all of which presented data on specific neural injury, therapy, and functional outcomes. Eight studies focused on the facial nerve (66.7%), two on the optic nerve (16.7%), one on the olfactory nerve (8.3%), and one on the hypoglossal nerve (8.3%). One study applied ADSCs to human cranial nerve injuries, while the remainder studied animal models. In these studies, ADSC groups had higher numbers of myelinated fibers, increased myelin thickness, and diameter of muscle fibers, as well as greater magnitude of compound muscle action potentials (CMAP) when compared to controls. In studies focused on optic nerve regeneration, significant improvements across visual tests were observed. ADSCs demonstrate potential utility in regard to their ability to facilitate functional recovery of cranial nerves in humans and animal models. As such, this therapy merits further investigation so that its true clinical applications can be determined.

## Full-text entities

- **Diseases:** nerve injuries (MESH:D000080902), neural injury (MESH:D014947), peripheral nerve injuries (MESH:D059348)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12321242/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12321242/full.md

---
Source: https://tomesphere.com/paper/PMC12321242